Unlike non-covalent interactions, covalent bonds are generally irreversible under physiological conditions. This irreversibility is a double-edged sword; while it can lead to long-lasting therapeutic effects, it can also result in prolonged toxicity. Strategies to mitigate this include the design of prodrugs that become activated only at the target site or the use of reversible covalent inhibitors.
